stockrowAMNEAL PHARMACEUTICALS, INC. (AMRX) vs Indivior Pharmaceuticals Inc. (SUPN)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.41 −2.71%
- Indivior Pharmaceuticals Inc. SUPN 28.21 +0.21%
AMNEAL PHARMACEUTICALS, INC. and Indivior Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. AMNEAL PHARMACEUTICALS, INC. is the larger, with a market value of $6.8B against $5.6B — 1.2× the size. Indivior Pharmaceuticals Inc. trades at the lower P/E: 7.6× against 36.9×. Indivior Pharmaceuticals Inc. grew revenue faster over the last twelve months: 16.4% against 8.88%. Indivior Pharmaceuticals Inc. has the higher net margin (32.9% vs 4.17%) and the higher return on invested capital (283.0% vs 8.45%). Across the 20 metrics below, Indivior Pharmaceuticals Inc. leads on 18 and AMNEAL PHARMACEUTICALS, INC. on 2.
Valuation
Profitability
| Metric | AMRX | SUPN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 40.24% | 84.85% | 53.51% |
| Operating margin | 14.99% | 40.57% | 0.00% |
| Net margin | 4.17% | 32.85% | (2.45%) |
| Free cash flow margin | (1.89%) | 2.26% | 0.00% |
| Return on equity | (53,107.17%) | (337.83%) | (0.80%) |
| Return on assets | 3.01% | 32.82% | (1.67%) |
| Return on invested capital | 8.45% | 283.03% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack